Baby Sehrish Fatima
Impact Guru, India's leading medical crowdfunding platform, has launched an urgent fundraising campaign for seven-month-old Sehrish Fatima from Delhi, who is battling Spinal Muscular Atrophy (SMA). Her life-saving treatment requires INR 16 crore, and time is of the essence.
In a remarkable show of support, within just 24 hours, over 80,000 donors have contributed INR 16 each, with over INR 92 Lakh raised in total. However, the road ahead is long, and Sehrish's family urgently needs the help of 10 lakh compassionate individuals to achieve the goal.
Her father, Nadeem Ahamad, has made a heartfelt appeal to the public, "We are desperate to save our little girl. We request 10 lakh people to come forward and donate just INR 160 each. This small contribution can make a huge difference in Sehrish's life."
Piyush Jain, Co-Founder and CEO of CarePal Group and Impact Guru, emphasized the power of collective action, "The generosity we've seen in such a short time is overwhelming. However, we still have a long way to go. With a small donation of INR 160 from 10 lakh people, we can give Sehrish the chance she deserves. Together, we can make the impossible possible."
In the recent past, Hridyansh, another child suffering from SMA type 1 received a lease of life when his parents succeeded in raising over INR 9 crore via Impact Guru with the support of 1.6 Lakh donors. He was administered Zolgensma gene therapy at JK Lone Hospital in Jaipur in May.
Baby Sehrish's fundraising campaign is a race against time, and every donation counts. Impact Guru is calling on all citizens to come together and contribute to this life-saving cause.
For more details about the campaign, please visit - https://www.impactguru.com/fundraiser/help-sehrish-fatima
Disclaimer: The views and opinions expressed in the article are media marketing initiative and do not represent the stand and views of Mid-Day Group. Mid-Day Group disclaims any and all liability to any party, company or product for any direct, indirect, implied, punitive, special, incidental or consequential damages arising directly or indirectly from the use of this content
